Strides Pharma Science Limited
Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products.The company's pharmaceutical products are sold in over 100 countries.The company has always followed an inorganic growth strategy over the years that resulted in foray into new markets, addition of new business segments, therapy segments and manufacturing infrastructure.
What Strides files
- Others53
- Investor Meet35
- Updates32
- Important31
- Board Meeting15
- Dividend/Bonus6
Strides Pharma Science Limited has informed the Exchange about completion of USFDA Inspection at the Company s Formulations Facility at Alathur
Strides Pharma's flagship Bengaluru facility received USFDA's Establishment Inspection Report, successfully closing the inspection. This positive regulatory update strengthens Strides' track record, ensuring continued product supply to global markets.
Strides Pharma Science Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 14, 2026. Further, the company has informed the Exchange regarding voting results.
Strides Pharma Science Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 14, 2026
Strides Pharma Science reported Q1 FY27 revenue up 13% YoY, with Ex-US revenue at ₹587.5 Cr ($63 Mn), growing 17% YoY despite temporary shipment delays. US revenue stood at ₹628.2 Cr ($68 Mn). EBITDA was ₹229.8 Cr (18.2% margin), up 5.4% YoY, absorbing ₹13.1 Cr in geopolitical-related costs. Reported PAT...